| October 4, 2023 |
|
| |
|
|
AM Portal | Abstracts | Exhibits | onDemand | Daily News
|
| |
|
|
| |
|
Outside forces shape our health, Bapu Jena addresses crowd during Tuesday’s Keynote
|
|
|
Tuesday morning, Anupam Bapu Jena, MD, PhD, led an interactive session to show how health is shaped by forces outside of our typical scope of thinking. Dr. Jena’s perspective is shaped by multiple illustrious roles, including the Joseph P. Newhouse Professor of Health Care Policy at Harvard Medical School, author of “Random Acts of Medicine” and previous host of the Freakonomics M.D. podcast. Read more.
|
|
| |
|
ASTRO honors leaders of the field
|
|
|
Yesterday morning, distinguished members of ASTRO were recognized for their service to the field and the Society during the 2023 Awards Ceremony. Twenty-nine members were designated ASTRO Fellows.
Simon Powell, MD, PhD, FASTRO, Najeeb Mohideen, MD, FASTRO, and Randall Ten Haken, PhD, FASTRO, were awarded the Gold Medal, ASTRO’s highest honor [picture: left]. Oliver Sartor, MD, was named ASTRO Honorary Member [picture: middle]. Paul Harari, MD, FASTRO, Fei-Fei Liu, MD, FASTRO, and Phuoc Tran, MD, PhD, were awarded the ASTRO Mentorship award [picture: right].
|
|
| |
|
| |
|
Abstract highlights
Thank you to the volunteers from the ASTRO Communications Committee; Research Grants Evaluation Subcommittee; Science Education and Program Development Subcommittee; and Promoting Science Through Research and Training Committee for providing expert commentary on scientific presentations and abstracts provided in the Daily News.
|
|
 |
Dynamic Tumor Tracking-Stereotactic Body Radiotherapy (DTT-SBRT) for Lung Tumors
Presenting author: Yukinori Matsuo, MD, PhD
This multi-institutional phase II study evaluates the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy (DTT-SBRT) for lung tumors treated 50 Gy in 4 fractions using a gimbal-mounted linear accelerator. This study reports their five-year survival and late toxicities observation. Read more.
|
|
 |
No Need to Escalate This
Presenting author: Nan Bi, MD, PhD
This study sought to better define the optimal dose for cTRT. Given recent trials showing a survival benefit of radiation dose escalation in patients with limited-stage small cell lung cancer, one could potentially see this benefit to translate to patients with ES-SCLC. Read more.
|
|
|
The Evolving Role of Radiotherapy in the Setting of CAR T: Moving toward the Driver’s Seat
Through the seemingly inexorable march toward greater omission of radiotherapy in the management of hematologic malignancies, each new paradigm shift can present an opportunity to re-engage our colleagues to consider optimal integration of radiotherapy in these new treatment paradigms, like chimeric antigen receptor (CAR) T-cell therapy, but how and when?
This commentary looks at studies from the SS 17 – HEME 1: Supercharged CAR T Cell Therapy: When, Where, and How Hard to Strike with Radiation for Lymphomas session, presented yesterday afternoon. Read more.
|
|
| |
|
Annual Business Meeting Highlights recap
|
|
|
During yesterday’s Annual Business Meeting, the passing of the gavel ceremony marked the start of the new board year, as Jeff Michalski, MD, MBA, FASTRO, assumed his new role as ASTRO Chair along with three new board members: Sameer Keole, MD, FASTRO, President-elect; Vivek Kavadi, MD, MBA, FASTRO, Health Policy Council Vice-chair; and Wendy Woodward, MD, PhD, FASTRO, Science Council Vice-chair.
Presentations during the luncheon, held for ASTRO voting members, included an overview on the ROI, the workforce study, a report on initiatives from the Early Career Committee and HEDI Council, and updates on ASTRO’s quality initiatives — APEx and RO-ILS. Dr. Michalski delivered remarks on ASTRO’s priorities for the year, including an analyses of Match data, medical student outreach, supporting rad oncs of the future, prioritizing RPTs and the DEI cultural audit.
The meeting concluded with an overview of the Radiation Oncology Case Rate (ROCR) program proposal, which is designed to reform radiation therapy reimbursement under Medicare by stabilizing payments and reducing disparities. Constantine Mantz, MD, FASTRO, Health Policy Council Chair, provided details on what’s included in the ROCR payment proposal and opened up the floor for questions and discussion. Overall, members showed enthusiasm for the proposal and called for unity in supporting the payment proposal.
|
|
| |
|
ROI 5k winners/raise $$ dollars for ROI
|
|
|
More than 500 people registered for the ROI 5k powered by Varian, a Siemens Healthineers Company! Congratulations to the fastest male finisher, Ben Li, MD, MBA who finished with a time of 15:37 and the fastest female finisher, Annie LaVigne, MD with a time of 20:01. MD Anderson Running Club took home the fastest academic team award, while Elekta was awarded the fastest corporate team. The annual RUN FOR RESEARCH raises funds for the Radiation Oncology Institute — ASTRO's research foundation — which is the only charity accelerating radiation oncology research and education.
|
|
| |
|
|
| |
|
CME and meeting evaluation reminders
|
|
Fill out the session evaluations and claim your CME credits on the meeting app. And please watch for an email with your personalized link to the meeting experience survey. Your feedback will help us improve your future meeting experiences.
|
|
| |
|
|
| |
|
|
